Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.
Two cancer care professionals, ideally from different disciplines, are trained over two years to implement comprehensive distress screening, evaluate that screening, refer the patient to additional resources if needed and properly document the results.
The participants attend two APOS conferences and learn how to implement live in workshops. Interested cancer care professionals can apply online at http://www.apos-society.org.
Less Than Half of Recently Approved Cancer Drugs Show a Clinical Benefit
Cadonilimab Plus Chemo Provides Survival Benefit in Gastric/GEJ Cancer
Lenvatinib Plus Pembrolizumab Improves Survival in Advanced/Recurrent Endometrial Cancer
Frontline Durvalumab Regimen Improves PFS, Responses in Advanced Endometrial Cancer
2 Commerce Drive
Cranbury, NJ 08512